Filters

Clear all

Expert Opinion

Plain Language Summary

Expert Review

Text Availability

Abstract

Full text

Free full text

Publication Types

Journal Article

Randomized Controlled Trial

Research Support, Non-U.S. Gov't

Comparative Study

Clinical Trial

Review

Multicenter Study

Systematic Review

Clinical Trial, Phase III

Meta-Analysis

Research Support, N.I.H., Extramural

Research Support, U.S. Gov't, P.H.S.

Clinical Trial, Phase I

Controlled Clinical Trial

Letter

Case Reports

Clinical Trial, Phase IV

Network Meta-Analysis

Equivalence Trial

Publication Year

From

Quick links

Individual year

2026

2025

2024

2023

2022

2021

2020

2019

2017

2016

2015

2014

2013

2012

2011

2010

2009

2008

2007

2006

2005

2004

2003

2002

2001

2000

Sort by:

selected

Print page

Email selected articles

Favourite selected articles

Create a NED Search Alert for this search

Save this search

Advanced Search

Run an advanced search

Results for
""Insulin Lispro""[mesh_terms]

95 Results

Searching titles within these results

Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.

Bruce W Bode

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2011;17(2):271-80

Full Text

Abstract

Determination of amyloid core regions of insulin analogues fibrils.

Alexey K Surin, Sergei Yu Grishin, Oxana V Galzitskaya

Prion 2021;14(1):149-162

Free Full Text

Abstract

Insulin analogues: have they changed insulin treatment and improved glycaemic control?

Sten Madsbad

Diabetes/metabolism research and reviews 2002;18 Suppl 1():S21-8

Full Text

Abstract

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.

Mark Warren, Bruce Bode, Jang I Cho, Rong Liu, Janet Tobian, Thomas Hardy, Farai Chigutsa, Moshe Phillip, Barry Horowitz, Debra Ignaut

Diabetes, obesity & metabolism 2021;23(7):1552-1561

Free Full Text

Abstract

Insulin pump therapy and rapid acting insulin: what have we learned?

B Zinman

International journal of clinical practice. Supplement 2001

Full Text

Abstract

Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.

M Vincent, E Nobécourt

Diabetes & metabolism 2014;39(4):299-305

Full Text

Abstract

Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.

Gérald E Piérard, André J Scheen, Régis P Radermecker

American journal of clinical dermatology 2007;8(1):21-8

Full Text

Abstract

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

Kevin Kaiserman, Henry Rodriguez, Amanda Stephenson, Linda Wolka, Jessie L Fahrbach

Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2012;18(3):418-24

Full Text

Abstract

The potential for the use of insulin lispro in pregnancy complicated by diabetes.

Kate J E Carr, Stephen W Lindow, Ewan A Masson

The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians 2006;19(6):323-9

Full Text

Abstract

Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?

Esther Chen, Maryann Mazer

Annals of emergency medicine 2009;53(2):259-63

Full Text

Abstract

Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.

J Skrha, A Smahelová, M Andĕl, M Vrtovec, J Subić, A Kreze, J Vozar, M Korecová, V de Verga, J Wyatt, S Metcalfe, S Ristić

Sbornik lekarsky 2002;103(1):15-21

Full Text

Abstract

Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.

A Moran, J Phillips, C Milla

Diabetes care 2001;24(10):1706-10

Full Text

Abstract

Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.

M Köse, C Erem, A Gunduz, A B Hacihasanoglu, S S Karti, H O Ersöz, K Ukinc

International journal of clinical practice 2006;60(4):429-33

Full Text

Abstract

New therapies for the pregnant patient with diabetes.

Y Y El-Sayed, D J Lyell

Diabetes technology & therapeutics 2002;3(4):635-40

Full Text

Abstract

Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.

L García, C Lamas, M J Tuset, M Alonso, R Barrio

Diabetes, nutrition & metabolism 2002;15(1):7-13

Full Text

Abstract

Results: 1 – 15 / 95

Filters

Expert Opinion

Text Availability

Publication Types

Publication Year

Results for ""Insulin Lispro""[mesh_terms]

Comparison of pharmacokinetic properties, physicochemical stability, and pump compatibility of 3 rapid-acting insulin analogues-aspart, lispro, and glulisine.

Determination of amyloid core regions of insulin analogues fibrils.

Insulin analogues: have they changed insulin treatment and improved glycaemic control?

Improved postprandial glucose control with ultra rapid lispro versus lispro with continuous subcutaneous insulin infusion in type 1 diabetes: PRONTO-Pump-2.

Insulin pump therapy and rapid acting insulin: what have we learned?

Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.

Lipodystrophy reactions to insulin: effects of continuous insulin infusion and new insulin analogs.

Continuous subcutaneous infusion of insulin lispro in children and adolescents with type 1 diabetes mellitus.

The potential for the use of insulin lispro in pregnancy complicated by diabetes.

Is subcutaneous administration of rapid-acting insulin as effective as intravenous insulin for treating diabetic ketoacidosis?

Insulin lispro improves postprandial glucose control in patients with diabetes mellitus.

Insulin and glucose excursion following premeal insulin lispro or repaglinide in cystic fibrosis-related diabetes.

Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.

New therapies for the pregnant patient with diabetes.

Treatment with the insulin analogue lispro in children and adolescents with type 1 diabetes mellitus: evaluation over a 3-year period.

Results for
""Insulin Lispro""[mesh_terms]